Peginterferon alfa-2b plus ribavirin for chronic hepatitis

被引:2
|
作者
Cecil, BD [1 ]
机构
[1] Louisville Vet Affairs Med Ctr, Hepatitis Virus Clin C, Louisville, KY 40206 USA
来源
LANCET | 2002年 / 359卷 / 9302期
关键词
D O I
10.1016/S0140-6736(02)07430-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:263 / 264
页数:2
相关论文
共 50 条
  • [1] Peginterferon alfa-2b plus ribavirin for chronic hepatitis - Reply
    Manns, MP
    McHutchison, J
    Koury, K
    Albrecht, JK
    [J]. LANCET, 2002, 359 (9302): : 264 - 264
  • [2] Peginterferon alfa-2b plus ribavirin for retreatment of chronic hepatitis C
    Dalke, DD
    Donovan, J
    Mailliard, M
    Monsour, H
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A667 - A667
  • [3] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
    Manns, MP
    McHutchison, JG
    Gordon, SC
    Rustgi, VK
    Shiffman, M
    Reindollar, R
    Goodman, ZD
    Koury, K
    Ling, MH
    Albrecht, JK
    [J]. LANCET, 2001, 358 (9286): : 958 - 965
  • [4] Peginterferon alfa-2b plus ribavirin versus interferon alfa-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients
    Crespo, M
    Sauleda, S
    Esteban, JI
    Juarez, A
    Buti, M
    Pahissa, A
    Esteban, R
    Guardia, J
    [J]. HEPATOLOGY, 2005, 42 (04) : 701A - 702A
  • [5] Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C
    Wirth, S
    Pieper-Boustani, H
    Lang, T
    Ballauff, A
    Kullmer, U
    Gerner, P
    Wintermeyer, P
    Jenke, A
    [J]. HEPATOLOGY, 2005, 41 (05) : 1013 - 1018
  • [6] Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Al-Ajmi, M
    Owaid, S
    Varghese, R
    Al-Nakib, B
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (09): : 1733 - 1737
  • [7] Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection
    Ascione, Antonio
    De Luca, Massimo
    Tartaglione, Maria Teresa
    Lampasi, Filippo
    Di Costanzo, Giovan Giuseppe
    Lanza, Alfonso Galeota
    Picciotto, Francesco Paolo
    Marino-Marsilia, Giuseppina
    Fontanella, Luca
    Leandro, Gioacchino
    [J]. GASTROENTEROLOGY, 2010, 138 (01) : 116 - 122
  • [8] Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
    Brixner, Diana I.
    Ye, Xin
    Chu, Teng-Chiao
    Blumentals, William A.
    Hassanein, Tarek I.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (24) : 2171 - 2178
  • [9] Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain
    Turnes, Juan
    Romero-Gomez, Manuel
    Planas, Ramon
    Sola, Ricard
    Garcia-Samaniego, Javier
    Diago, Moises
    Crespo, Javier
    Calleja, Jose Luis
    Rubio-Terres, Carlos
    Ventayol, Pere
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (09): : 555 - 564
  • [10] Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium
    Wong, JB
    Nevens, F
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (02): : 110 - 111